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ZnO nanospheres of average diameter of 5.0±0.2 nm have been 
prepared by simple hydrothermal method using sodium alginate as 
a template. The prepared ZnO nanospheres are characterized by 
XRD, TEM, EDX and fluorescence spectra. The photodegradation 
of the drugs diclofenac (DCF) and chloramphenicol (CHL) are 
studied in presence of UV light of wavelength 365 nm. Formation 
of wurtzite structure of ZnO nanospheres is confirmed by XRD 
analysis. The decrease in intensity of fluorescence emission 
spectra of the nanospheres indicated the interaction between the 
drug molecules and the excited species. The peroxide radicals and 
the hydroxyl radicals formed due to electron and the hole further 
affect the degradation of the drug molecules. The TOC content of 
DCF and CHL is reduced to 12.8% and 6.8% after 180 min under 
the conditions of the reaction. 
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The pharmaceutical industry manufactures various 
chemical compounds used as prescriptions in 
treatment of wide range of diseases. Some amounts of 
these pure drugs are found to be present in the waste 
generated during their large scale industrial 
production1-6. These drug containing effluents are also 
found to affect the plants7 apart from their 
toxicological effect8-10. Efforts have been made to 
develop means by which the contaminated water 
resources are to be purified11-15. Therefore, 
development of new energy efficient, cost effective 
and environmentally benign methods has received 
considerable attention during recent past. Diclofenac 
(DFC), derived from benzene acetic acid is a non-
steroidal antiinflammatory drug of cyclooxygenase 
inhibitor16 used in the treatment of osteoarthritis, 
rheumatoid arthritis, and ankylosing spondylitis, while 
chloramphenicol17 is an antibiotic. Both these drugs 
are found to be present in waste water and require 
treatment11-15 due to their high insistence and low 
biodegradability. Methods like advanced oxidation 
processes (AOPs) are being utilized for treatment of 
polluted aqueous environments.  
The degradation or mineralization of these drugs 
have been investigated both by uncatalyzed18,19 and 
catalyzed20-29 photochemical methods as well as by 
electrochemical method30. The probable mechanism of 
photodegradation of dyes or pharmaceuticals is 
through the generation of electron hole pair. The main 
disadvantage of these methods is the rapidness of the 
combination of these electron hole pairs, thus 
decreasing the efficiency of the photocatalyst. 
Therefore, to overcome the recombination, these 
photocatalysts like TiO2 or ZnO are supported on 
various substrates31. These supports reduce the 
recombination rate by offering an alternative 
mechanism for the electron transport.  
Nanomaterials are promising candidates due to 
their unique physicochemical properties due to large 
surface/volume ratios32,33. These nanomaterials have 
been utilized as solutions for environmental problems 
as either photocatalysts or as catalysts for advanced 
oxidation processes in presence of sacrificing 
oxidants32,33. One such material is zinc oxide (ZnO) 
with a wide band gap energy of 3.37 eV at room 
temperature which in its nano form enhances catalytic 
properties in presence of reduced graphene oxide31. In 
literature, a variety of methods have been employed 
for the ZnO nanostructures with different 
morphologies34-36. These methods suffer drawbacks 
like low dispersion of starting materials and wide 
particle size distribution and to overcome this 
difficulty, polymer templates have been used37. In the 
present study, an attempt has been made to utilize 
sodium alginate as a polymer template to prepare ZnO 
nanomaterial and its application for treatment of 
pharmaceutical effluents contaminated with the drugs 
like diclofenac and chloramphenicol has been studied. 
 
Experimental 
Zinc sulfate heptahydrate, sodium hydroxide and 
sodium alginate were of analytical reagent grade 
obtained from SD Fine Chemicals (Mumbai, India) 
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and deionized water was used for the preparation of 
solutions. Chloramphenicol and diclofenac sodium 
salt (99.5% purity) were purchased from Sigma-
Aldrich and were used as obtained. Doubly distilled 
water was used to prepare the buffer solution by 
adding appropriate amounts of NaOH (0.1 mol/L) or 
HCl (0.1 ml/L) from Merck. 
ZnO nanospheres were synthesis as follows: To an 
aqueous solution of zinc sulfate( 0.01 mol dm-3,100 mL), 
sodium alginate (1 g) as a polymer template was added 
with constant stirring followed by the dropwise 
addition of sodium hydroxide solution( 0.02 mol dm-3, 
100 mL) in a molar ratio of 1:2 under vigorous stirring 
for 12 h. The template containing the highly viscous 
mixture was poured on cleaned glass plate to make 
thin films. The thickness of the prepared films was 
measured with the help of micrometer screw gauge 
and was found to be 40±3 µm. These films were 
allowed to dry and were heated at 550 °C in a muffle 
furnace (Bio-Technics, India) and maintained at that 
temperature for 5 h, after which it was cooled to room 
temperature at a rate of 10 °C/min. The resulting solid 
product was used for characterization and as a catalyst 
for drug degradation. 
X-ray diffraction (XRD) measurements were made 
using Goniometer Rigaku Ultima IV diffractometer 
with Cu-K beta source. The energy dispersive X-ray 
analysis was made using a Hitachi S-4700 instrument 
The TEM images were recorded on Phillips CM 200 
instrument. The fluorescence spectra of ZnO 
nanospheres were recorded on JASCO FP 750 
spectrofluorimeter at an excitation wavelength of  
334 nm from 430–700 nm. The fluorescence spectra 
of pure ZnO nanospheres and in presence of 
diclofenac and chloramphenicol were recorded. 
For the photocatalytic degradation experiments, 
stock solutions of diclofenac (DCF) and 
chloramphenicol (CHL) (100 ppm each) were 
prepared in doubly distilled water and diluted to the 
desired concentrations. The experimental setup 
consisted of a 300 mL cylindrical reactor with a quartz 
tube at the center of the reactor, UV light source (λmax 
= 365 nm), a water jacket provided for cooling, fitted 
with a magnetic stirrer. During the degradation 
experiments, to a solution (230 mL) of either 
chloramphenicol or diclofenac, an appropriate 
quantity of the zinc oxide was added and stirred 
magnetically for half an hour to establish absorption 
equilibrium. After the establishment of the adsorption 
equilibrium, the UV light source was switched on and 
aliquots of the mixture were withdrawn at regular 
intervals. The catalyst in the aliquots was removed by 
centrifugation. The concentration of the remaining 
DCF and CHL were determined by measuring their 
absorbance at 276 and 278 nm respectively18, 20 on a 
Specord 210 plus UV-vis spectrophotometer. The 
degradation reaction was monitored up to 180 min. 
The kinetics of degradation was followed by plotting 
(C/C0) against time where C0 and C represent the 
initial concentration and the concentration at time t of 
either DCF or CHL respectively. The total organic 
carbon (TOC) of the reaction mixtures for both DCF 
and CHL were also determined as a function of time 
on Multi N/C 2100 TOC Instrument (Analytik Jena 
Instrumentation). 
 
Results and discussion 
The XRD of the ZnO nanospheres shows peaks at 
2θ (°) = 31.79, 34.66, 36.2, 47.56, 56.45, 62.69, 68.12, 
72.78, 76.77, 81.2, corresponding to (100), (002), 
(101), (102), (110), (103), (201), (004), (202) and (104) 
planes respectively. The spectrum matches the 
reported31 hexagonal wurtzite structure (JCPDS 80-
0074) of ZnO. The energy dispersive X-ray analysis 
(EDX) spectrum (Fig. 1) shows the presence of  
Zn and O and the molar ratio of Zn:O was found  
to be 1:1.74. The TEM images are shown in Fig. 2 
along with SAED pattern. It can be noticed that 
 the ZnO particles have nanosphere morphology of an 
average size of 5.0±0.2 nm as determined from TEM 
image (Fig. 2). The size of ZnO nanospheres was 
determined from TEM image and the minimum size of 
sphere was found to be 4.29 nm, while the maximum 
size was 6.16 nm. The average size of the nanosphere 




Fig. 1 – EDAX spectrum of ZnO nanospheres. 




The fluorescence spectrum of ZnO nanospheres at 
an excitation wavelength of 334 nm shows an 
emission peak at 530 nm due to electron-hole 
recombination38 (Fig. 3). The intensity of the emission 
peak at 530 nm of ZnO nanospheres decreases in 
presence of diclofenac and chloramphenicol, 
indicating an interaction between the drug molecules 
and the excited ZnO nanospheres. The excitation  
of ZnO occurs due to absorption of light, and the 
emission is due to electron hole combination. 
However, since the emission in presence of either 
drugs is not observed, it indicates that the excited  
hole and electron interact with the drug molecules, 
thus offering an alternative path for the decay.  
Such an interaction also further leads to the 
degradation of the drugs. 
The effect of amount of catalyst on 
photodegrdation of DCF and CHL was studied 
between 0 and 100 mg at a concentration of 10 ppm of 
each drug. The rate constants for degradation of DCF 
and CHL are given in Table 1. The photodegradation 
without catalyst is negligible for both the drugs, while 
it was observed that the photodegradation increased 
with increase in the amount of catalyst till 50 mg 
(Table 1) and thereafter there is no significant 
increase. The increase in photodegradation with an 
increase in the amount catalyst depends on the total 
illumination of the ZnO particles and at an amount of 
catalyst more than 50 mg, turbidity hinders further 
penetration of light into the reactor thus limiting the 
photodegradation activity to a maximum value 
The effect of initial concentration of either DCF or 
CHL was carried out from 8–14 ppm in presence of 
50 mg of catalyst. It was observed that complete 
degradation of 10 ppm of DCF and CHL is achieved 
at 180 min, while it decreases with increase in initial 
concentration of drugs. This may be due to the fact 
that at higher concentrations, the drug molecules 
present in the solution may interrupt the path of 
photons reaching the catalyst surface. 
The general mechanism31 of photocatalysis by ZnO 














Fig. 3 – Fluorescence spectra of ZnO nanospheres in presence of 
diclofenac (solid line) (dotted line), and in presence of 
chloramphenicol (dashed line). 
Table 1 – Rate constants for the photodegradation of DCF and 
CHL at different concentration of catalysts in water at 25 °C. 
{[DCF] = [CHL] = 10 ppm} 
 
Amt of catalyst 
(mg) 
10 3 Rate constant (min-1) 
Diclofenac Chloramphenicol 
0.0 0.91 1.60 
30.0 9.21 6.93 
50.0 13.8 9.24 
70.0 6.91 4.61 
100.0 4.60 4.62 
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result of excitation of its valance band electron  to  the  
conduction band. The electron will further react with 
dissolved oxygen to form peroxide radical whereas the 
hole will react with the water to produce hydroxyl 
radical. Therefore, the mechanism of degradation of 
both the drugs DCF and CHL under the present 
conditions is initiated by the generation of electron 
hole pair due to the absorption of light by ZnO 
nanospheres. The intermediate peroxide free radicals 
and the hydroxyl radicals from generated electron and 
hole respectively will further effect the degradation of 
the drugs as shown in Scheme 1. In order to 
understand the total mineralization of the drugs, the 
total organic content (TOC) was analyzed as a 
function of time for both the drugs and the results are 
shown in Figs 4 and 5. The changes in the absorbance 
for DCF and CHL at 276 and 278 nm respectively are 
also shown in Figs 4 and 5 for comparison. From  
Figs 4 and 5 it can be noticed that the decrease in the 
absorbance is parallel to the decrease in TOC for both 
the drugs. The total TOC for DCF is 12.33%, while 
for CHL it is 6.83%, indicating that both the drugs are 
degraded almost completely within 180 min in 
presence of ZnO nanospheres. The mechanism of 
degradation of diclofenac39,40 and chloramphenicol41 
have been studied using various photocatalysts. The 
degradation of diclofenac generally proceeds through 
two hydroxylation steps due to its reaction with 
photogenerated hydroxyl radicals. The hydroxylated 
product further reacts with either the hydroxyl radicals 
or holes undergoing complete mineralisation. In the 
case of  chloramphenicol,  initially  two  intermediates  
were predicted due to loss of either dicloroacetic acid 
moiety or denitration. Removal of dicloroacetic acid 
moiety leads to 4-(2-Amino-1,3-dihydroxy-propanyl)-
nitrobenzene, while denitration generates 2,2-dicloro-
N-[1,3-dihydroxy-1-(4-hydroxyphenyl)-propan-2-yl]-
acetamide. Both these two products react with 
photogenerated hydroxyl radicals and holes leading to 
the complete mineralisation.  
The photodegradation of both the drugs was found to 
increase up to 50 mg of catalyst and thereafter there 
was no significant increase. The increase in 
photodegradation with an increase in the catalyst 
amount depends on the total illumination of the ZnO 
particles and with more than 50 mg catalyst, turbidity 















Mechanism of photodegrdation of diclofenac and chloramphenicol 






Fig. 4 – Variation of TOC (%) and absorbance at 276 nm as a 




Fig. 5 – Variation of TOC (%) and absorbance at 278 nm as a 
function of time for CHL. 
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reaching a limiting value for the photodegradation. 
Similarly, complete degradation of 10 ppm of DCF and 
CHL is achieved at 180 min, which decreases with 
increase in initial concentration of drugs. This may be 
due to the fact that at higher concentrations, the drug 
molecules present in the solution may interrupt the path 
of photons reaching the catalyst surface.  
In conclusion, ZnO nanospheres have been 
prepared by hydrothermal method in presence of 
sodium alginate as a template. The XRD of ZnO 
nanospheres indicates formation of wurtzite structure 
with the average size of nanospheres found to be 
5.0±0.2 nm as obtained from TEM analysis. The EDX 
analysis shows the presence of Zn and O elements 
with the ratio 1:1.74. The fluorescence spectrum of the 
nanospheres shows a band gap excitation emission, 
the intensity of which decreases in presence of drug 
molecules. Such a decrease indicates the interaction 
between the drug molecules and the species obtained 
as a result of excitation of an electron from the 
conduction band to the valance band of ZnO. The 
degradation of the drug molecules was also confirmed 
by measuring the total organic content (TOC). The 
drugs were found to be degraded within 180 min. The 
mechanism proposed involves formation of electron 
hole pair leading to the formation of reactive species. 
The reaction between reactive species, hydroxyl and 
peroxide radicals, obtained in solution leads to the 
degradation of the drug molecules. The method of 
synthesis is simple and the ZnO nanospheres are 
found to be a efficient heterogeneous photocatalyst in 
presence of UV light of wavelength 365 nm. 
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